News and Resources

News and resources

IFFIm finances Gavi’s groundbreaking malaria vaccine programme

17 Dec 2024

Gavi’s achievements in rolling out the malaria vaccine are a historic breakthrough in the fight against one of the world's deadliest diseases. With critical, flexible financing from IFFIm, the malaria vaccine will protect millions of young lives and reshape health systems in malaria-prone regions.

"IFFIm has an advantage in that its purpose is crystal clear"

17 Dec 2024

An interview with IFFIm Board Member Eila Kreivi.

A look back: how sukuk diversified IFFIm’s investor base and portfolio

17 Dec 2024

IFFIm’s strategic use of Islamic investment certificates, or sukuk, in past years has been an important factor in diversifying both its investor base and investment portfolio, ensuring that Gavi’s vaccination programmes can continue to make an impact globally.

Mobilising resources to save lives

17 Dec 2024

As countries face budget constraints, IFFIm will play a critical role in Gavi’s 2026-2030 funding.

The real Diehl

16 Dec 2024

An interview with IFFIm Board Member Jeff Diehl.

IFFIm earns A+ rating from the UK for the sixth consecutive year, solidifying its role in Gavi’s global immunisation efforts

14 Nov 2024

For the sixth consecutive year, the International Finance Facility for Immunisation (IFFIm) has been awarded an A+ rating by the United Kingdom’s Foreign, Commonwealth & Development Office (FCDO).

IFFIm Board of Directors attend key meetings with Gavi, World Bank in Washington, DC to bolster support for Gavi’s 6.0 strategy and prepare for bond transaction

14 Nov 2024

At an 8 October event at the World Bank, IFFIm’s Board and the Gavi IFFIm-focused Secretariat team met with Gavi’s Audit and Finance Committee (AFC) to provide a technical briefing on IFFIm, its partnership with the World Bank and evolving role in partnership with Gavi.